• selection of high risk pharmaceutical products (PPs)
  
  
• application of novel cleanup, concentration and diagnostic methods as well as HTSAs for monitoring PPs in environmental, food and human patient samples
  
  
• studies of the mechanisms of action of high risk PPs in vitro, in situ and in vivo
  
  
• monitoring fecundity problems in target populations in relation to dietary habits (epidemiological study)
  
  
• development of risk management strategies
  
  
• establishment of web based knowledge pools, publication and communication of data

project brochure